Position overviewPosition title: Oncology Imaging Fellow/Health Sciences Clinical Instructor
Open date: August 1st, 2022
Next review date: Friday, Dec 30, 2022 at 11:59pm (Pacific Time)
Apply by this date to ensure full consideration by the committee.
Final date: Friday, Mar 31, 2023 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
The UCLA Oncology Imaging fellowship is a new comprehensive one year clinical fellowship concentrated in multi-modality cancer imaging, including CT, MRI, PET/CT, PET/MR; and if desired, exposure to image-guided oncology procedures. In addition to providing a strong foundation in body imaging, this training program will allow fellows to become proficient in imaging performed for the selection, planning and monitoring of treatment in cancer care.
Fellows will gain proficiency in standard of care cross sectional imaging, including abdominal MRI, chest CT, abdominal CT, and whole body MRI, as well as gain expertise in standardized response assessment of clinical trial imaging. Fellows will also participate in the PET/CT and PET/MR services, imaging services jointly staffed by the Departments of Nuclear Medicine and Radiology to gain interpretive skills with multiple PET radiopharmaceuticals, including PSMA PET.
Fellows will actively participate in many multidisciplinary cancer programs and tumor boards at UCLA Jonsson Comprehensive Cancer Center. This experience affords an opportunity to gain familiarity with types of cancer treatments, role of localized therapy, as well as imaging patterns of tumor specific metastases, disease recurrence and drug toxicity.
• MD/DO degree
• Completion of a Radiology Residency
• Must be eligible and obtain full licensure by the California Medical Board by the start of fellowship 07/01/2024
Universal Fellowship Application - Please fill out the Fellowship Application:
Curriculum Vitae - Your most recently updated C.V.
USMLE/COMLEX Score Reports
Medical School Diploma
Statement on Contributions to Equity, Diversity, and Inclusion - An EDI Statement describes a faculty candidate’s past, present, and future (planned) contributions to equity, diversity, and inclusion. To learn more about how UCLA thinks about contributions to equity, diversity, and inclusion, please review our Sample Guidance for Candidates and related EDI Statement FAQ document.
Misc / Additional (Optional)
- 3 letters of reference required
3 letters of recommendation are required. Please have your letter writers upload their letters.
Help contact: firstname.lastname@example.org
As a condition of employment, you will be required to comply with the University of California SARS-CoV-2 (COVID-19) Vaccination Program Policy. All Covered Individuals under the policy must provide proof of Full Vaccination or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, and/or Religious Objection) or Deferral (based on pregnancy) no later than the applicable deadline. New University of California employees must (a) provide proof of receiving at least one dose of a COVID-19 Vaccine no later than 14 calendar days after their first date of employment and provide proof of Full Vaccination no later than eight weeks after their first date of employment; or (b) if applicable, submit a request for Exception or Deferral no later than 14 calendar days after their first date of employment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.
The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age or protected veteran status. For the complete University of California nondiscrimination and affirmative action policy, see: UC Nondiscrimination & Affirmative Action Policy.